The largest database of trusted experimental protocols

9 protocols using carbenoxolone

1

IP3 ELISA for Colonoid Phytate Response

Check if the same lab product or an alternative is used in the 5 most similar protocols
Fecal and IEC pellets were homogenized in cold PBS and extract was collected after centrifugation at 4°C. For mouse colonoids, organoids were cultured in a 24 well plate and treated with phytase-digested phytate (1 mg/ml) supplemented with vehicle (DMSO) or 40 μM of carbenoxolone (Tocris)24 (link),40 for 20 hours. After treatment, colonoids were homogenized and 50 μg of lysate was used for IP3 ELISA. IP3 ELISA was performed on equal protein quantities of IEC lysate and fecal extract according to manufacturer instructions (MyBiosource). Briefly, samples were incubated with 50 µl of biotinylated detection antibody for 45 minutes at 37ºC, washed 3 times, and incubated with HRP conjugate at 37 ºC for 30 minutes. The plate was rinsed with wash buffer followed by substrate incubation for 15 minutes at 37 ºC. The reaction was stopped and the optical density of each well was measured using a micro-plate reader (Biotek Synergy 2) set to 450 nm.
+ Open protocol
+ Expand
2

IP3 ELISA for Colonoid Phytate Response

Check if the same lab product or an alternative is used in the 5 most similar protocols
Fecal and IEC pellets were homogenized in cold PBS and extract was collected after centrifugation at 4°C. For mouse colonoids, organoids were cultured in a 24 well plate and treated with phytase-digested phytate (1 mg/ml) supplemented with vehicle (DMSO) or 40 μM of carbenoxolone (Tocris)24 (link),40 for 20 hours. After treatment, colonoids were homogenized and 50 μg of lysate was used for IP3 ELISA. IP3 ELISA was performed on equal protein quantities of IEC lysate and fecal extract according to manufacturer instructions (MyBiosource). Briefly, samples were incubated with 50 µl of biotinylated detection antibody for 45 minutes at 37ºC, washed 3 times, and incubated with HRP conjugate at 37 ºC for 30 minutes. The plate was rinsed with wash buffer followed by substrate incubation for 15 minutes at 37 ºC. The reaction was stopped and the optical density of each well was measured using a micro-plate reader (Biotek Synergy 2) set to 450 nm.
+ Open protocol
+ Expand
3

Detailed Reagents Preparation Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
ATP, carbenoxolone and ethidium bromide were from Sigma-Aldrich (St. Louis, MO, USA). Probenecid (water-soluble) and lucifer yellow were from Invitrogen (Carlsbad, CA, USA). AZ11645373, carbenoxolone, AZ10606120, 10Panx1 and scrambled peptides were from Tocris Biosciences (Bristol, UK). ethidium bromide (5 mM) and lucifer yellow (1.6 mg/ml) were prepared in distilled water and stored at 4°C, Probenecid (250 mM) was prepared in distilled water and stored at −30°C. AZ11645373 (50 mM) and AZ10606120 (10 mM) were prepared in DMSO and stocks frozen at −30°C. carbenoxolone (50 mM) was prepared fresh before each experiment in distilled water or saline buffer. 10Panx1 and scrambled peptides (1 mM) were prepared in DMSO and stored at −80°C.
+ Open protocol
+ Expand
4

Astrocyte Response to Hypotonic Stress

Check if the same lab product or an alternative is used in the 5 most similar protocols
Rat and mouse optic nerve head astrocytes were subcultured onto plastic 6-well plates and grown until confluent. Cells were incubated in control isotonic solution containing (in mM) 105 NaCl, 5 KCl, 4 NaHEPES, 6 HEPES acid, 1.3 CaCl2, 5 glucose, 5 NaHCO3 and 60 mannitol, pH 7.4 or in solution made 30% hypotonic solution by addition of dH20, for 4 h in the tissue culture incubator. Cells were pretreated with inhibitors Bay 11-7082 (4 μM), Brilliant blue G (BBG, 10 μM), A839977 (50 nM, Tocris Bioscience), A740003 (5 μM, Tocris Bioscience), carbenoxolone (10 μM, #C4790), probenecid (1 mM, #P8761) or 10Panx1 and scrambled peptide (100 μM, #3348 and #3708, respectively, Tocris Bioscience) for 1 h before adding test solutions. RNA was extracted immediately after the 4 h treatment.
+ Open protocol
+ Expand
5

Pharmacological Dissection of Striatal Neurotransmission

Check if the same lab product or an alternative is used in the 5 most similar protocols
We used bicuculline (10 μM, Sigma) to block GABAA receptors. Dihydro-β-erythroidine hydrobromide (DhβE; 1 μM, Tocris) was used to block nAChRs that contain β2-subunits including Type 2 nicotinic receptors (α4β2), and some heterormeric Type III nAChRs (β2*-containing). Methyllycaconitine citrate (MLA; 500 nM, Tocris) was used as an antagonist of nAChRs containing the α7 subunit (Type I nAChRs) mostly expressed presynaptically by glutamatergic afferents in the striatum, mecamylamine hydrochloride (MEC; 5 μm, Tocris) was used as a non-selective nAChRs antagonist that preferentially block Type III nAChRs [heterotrimeric α3β2β4, (Albuquerque et al., 1995 (link), 2009 (link))]. Atropine (Sigma, 10 μM) and scopolamine (Tocris, 10 μM) were used as non-selective mAChRs antagonists and VU0255035 (Tocris, 10 μM) as a selective M1 mAChR antagonist. CNQX (10 μM, Tocris) and APV (10 μM, Tocris) to block respectively AMPA and NMDA glutamate receptors. We used tetrodotoxin (TTX, 1 μM, Sigma) in association with 4-aminopyridine (4-AP, 200 μM, Tocris) to isolate monosynaptic responses. Finally, to block gap junction (electrotonic) communication we used carbenoxolone (100 μM, Tocris).
+ Open protocol
+ Expand
6

Piezo1 Agonist Chemical Treatments

Check if the same lab product or an alternative is used in the 5 most similar protocols
For this study, we used chemical treatments of HMR1556 20 μM (Sigma-Aldrich), Thapsigargin 10 μM (Sigma-Aldrich), Apyrase 10U (Sigma-Aldirch), Carbenoxolone 100 μM (Tocris), GsMTx4 1 μM (Tocris), Yoda1 100 μM (Tocris), and Jedi2 40 μM (Tocris). Concentrations were based on previous work and from testing a variety of concentrations of Piezo1 agonists (S6 Fig). HMR1556 was stored at 10 mM concentration at −20°C. Thapsigargin was stored at 10 mM concentration at −20°C. Apyrase was stored at 100U in −20°C. GsMTx4 was stored at 1 mM at −20°C. Yoda1 was stored at 10 mM at 4°C in 100% DMSO. Jedi2 was stored at 10 mM at 4°C. All treatments were done in 2% DMSO. Control groups were treated with 2% DMSO throughout.
+ Open protocol
+ Expand
7

Pharmacological Dissection of Striatal Neurotransmission

Check if the same lab product or an alternative is used in the 5 most similar protocols
We used bicuculline (10 μM, Sigma) to block GABAA receptors. Dihydro-β-erythroidine hydrobromide (DhβE; 1 μM, Tocris) was used to block nAChRs that contain β2-subunits including Type 2 nicotinic receptors (α4β2), and some heterormeric Type III nAChRs (β2*-containing). Methyllycaconitine citrate (MLA; 500 nM, Tocris) was used as an antagonist of nAChRs containing the α7 subunit (Type I nAChRs) mostly expressed presynaptically by glutamatergic afferents in the striatum, mecamylamine hydrochloride (MEC; 5 μm, Tocris) was used as a non-selective nAChRs antagonist that preferentially block Type III nAChRs [heterotrimeric α3β2β4, (Albuquerque et al., 1995 (link), 2009 (link))]. Atropine (Sigma, 10 μM) and scopolamine (Tocris, 10 μM) were used as non-selective mAChRs antagonists and VU0255035 (Tocris, 10 μM) as a selective M1 mAChR antagonist. CNQX (10 μM, Tocris) and APV (10 μM, Tocris) to block respectively AMPA and NMDA glutamate receptors. We used tetrodotoxin (TTX, 1 μM, Sigma) in association with 4-aminopyridine (4-AP, 200 μM, Tocris) to isolate monosynaptic responses. Finally, to block gap junction (electrotonic) communication we used carbenoxolone (100 μM, Tocris).
+ Open protocol
+ Expand
8

Multichannel Extracellular Recordings in Visual Cortex

Check if the same lab product or an alternative is used in the 5 most similar protocols
Multichannel extracellular recordings were collected at 25 kHz using a linear 16-channel probe configuration (A16x1-2 mm-100–177, NeuroNexus; electrode separation, 100 μm). This was connected to an ME16-FAI-μPA system and MC-Rack software (Multichannel Systems). The signals were filtered using an analog high-pass filter with a 300 Hz cutoff frequency. Data acquisition was conducted using a 1401–3 Analog-Digital converter (Cambridge Electronic Design) and Spike2 software (Cambridge Electronic Design). The electrode array was placed along layer V in the occipital dorsal area of neocortex, approximately corresponding to primary visual cortex (Dong, 2008 ). Channelrhodopsin was activated by a 470 nm LED, delivering light through a Nikon Plan Fluor 4× objective (numerical aperture, 0.13), using the patterned illuminator Polygon400 (Mightex). The system was controlled and the patterns were designed through the PolyScan 2 software from the same company. The light intensity was measured at ∼2 mW/mm2.
AMPA currents were blocked by bathing in 20 μm NBQX (HelloBio), and NMDA currents were blocked using 50 μm d-APV (Abcam). GABAA receptors were blocked by gabazine (20 μm). We used three different gap junction blockers, namely mefloquine (50 μm) and quinine (100 μm; both from Sigma-Aldrich); and carbenoxolone (100 μm; Tocris Bioscience).
+ Open protocol
+ Expand
9

Pharmacological Modulation of Neural Circuits

Check if the same lab product or an alternative is used in the 5 most similar protocols
Drugs that were used include bicuculline (10μM, Sigma) to block GABA A receptors, Dihydro-βerythroidine hydrobromide (DhβE; 1μM, Tocris) to block type 2 nicotinic receptors (containing β2-subunits), methyllycaconitine citrate (MLA; 500nM, Tocris) as an antagonist of type I nicotinic receptors (containing α7-subunits), mecamylamine hydrochloride (MEC; 5 μm, Tocris), Atropine (Sigma, 10μM) to block muscarinic receptors, CNQX (10μM, Tocris) and APV (10μM, Tocris) to block respectively AMPA and NMDA glutamate receptors. To block gap junction (electrotonic) communication we used carbenoxolone (100μM, Tocris).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!